Sanofi Supports AlphaDetect to Expedite Detection of Alpha-1 Antitrypsin Deficiency

Sanofi is providing support to AlphaDetect to help speed up the detection of Alpha-1 antitrypsin deficiency (Alpha-1). The collaboration aims to improve early diagnosis and management of this underdiagnosed genetic condition.

Alpha-1 is often missed or diagnosed late because its symptoms can resemble other respiratory illnesses. Sanofi’s support will enable AlphaDetect to expand its screening programs and increase awareness among healthcare professionals and the public. By facilitating earlier detection, the collaboration hopes to improve patient outcomes and reduce the long-term complications associated with Alpha-1.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: May 6, 2026

Author

GOAI